Art

J-GLOBAL ID：201502281217322497   Reference number：15A0236824

Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results

多発性硬化症におけるナタリズマブの有効性と安全性: 中間観察プログラムの結果

Author (19)： BUTZKUEVEN Helmut (Univ. of Melbourne, Victoria, AUS) ,  BUTZKUEVEN Helmut (Monash Univ., Victoria, AUS) ,  BUTZKUEVEN Helmut (TYSABRI Observational Program (TOP) Investigators) ,  KAPPOS Ludwig (Univ. Hospital Basel, Basel, CHE) ,  KAPPOS Ludwig (TYSABRI Observational Program (TOP) Investigators) ,  PELLEGRINI Fabio (Consorzio Mario Negri Sud, Chieti, ITA) ,  PELLEGRINI Fabio (TYSABRI Observational Program (TOP) Investigators) ,  TROJANO Maria (Organs, Univ. of Bari, Bari, ITA) ,  TROJANO Maria (TYSABRI Observational Program (TOP) Investigators) ,  WIENDL Heinz (Univ. of Muenster, Muenster, DEU) ,  WIENDL Heinz (TYSABRI Observational Program (TOP) Investigators) ,  PATEL Radhika N (Biogen Idec Inc, Massachusetts, USA) ,  PATEL Radhika N (TYSABRI Observational Program (TOP) Investigators) ,  ZHANG Annie (Biogen Idec Inc, Massachusetts, USA) ,  ZHANG Annie (TYSABRI Observational Program (TOP) Investigators) ,  HOTERMANS Christophe (Biogen Idec Inc, Massachusetts, USA) ,  HOTERMANS Christophe (TYSABRI Observational Program (TOP) Investigators) ,  BELACHEW Shibeshih (Biogen Idec Inc, Massachusetts, USA) ,  BELACHEW Shibeshih (TYSABRI Observational Program (TOP) Investigators)
Material： Journal of Neurology Neurosurgery & Psychiatry  (Journal of Neurology, Neurosurgery, and Psychiatry)
Volume： 85  Issue： 11  Page： 1190-1197  Publication year： Nov. 2014 
JST Material Number： T0138A  ISSN： 0022-3050  Document type： Article
Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Terms in the title (5)： 多発性硬化症 ,  ナタリズマブ ,  有効性 ,  安全性 ,  観察